Animal model for liver cell banking from non-heart beating donors after prolonged ischaemia time

Digestive and Liver Disease

Volumn 38, Issue 12, 2006, Pages 905-911

  Porretti, L ^a   Gatti, S ^a   Gramignoli, R ^a   Colombo, F ^a   Lopa, R ^a   Cattaneo, A ^a   Scalamogna, M ^a   Colombo, G ^a   Rossi, G ^a   Bonino, F ^a   Rebulla, P ^a   Prati, D ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b A MANZONI HOSPITAL   (Italy)

Author keywords

Hepatocytes; Non heart beating donor; Rat; Warm ischaemia

Indexed keywords

ALBUMIN; CELL MARKER; UREA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL LIVER; CADAVER DONOR; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ISCHEMIA; LIVER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRESERVATION; RAT; TIME OF DEATH;

ANIMALS; CELL SEPARATION; CELL SURVIVAL; CRYOPRESERVATION; HEART ARREST; HEPATOCYTES; ISCHEMIA; LIVER; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE BANKS; TISSUE DONORS;

EID: 33751294902     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.07.009     Document Type: Article

References (27)

1. Bonn D. Hybrid devices offer hope for the failing liver. Lancet 348 (1996) 1372
2. Lee W.M. Acute liver failure. N Engl J Med 329 (1993) 1862-1872
3. Kjaergard L.L., Liu J., Als-Nielsen B., and Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure. J Am Med Assoc 289 (2003) 217-222
4. Li L.J., Yang Q., Huang J.R., Xu X.W., Chen Y.M., and Fu S.Z. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol 10 (2004) 2984-2988
5. Allen J.W., Hassanein T., and Bathia S.N. Advances in bioartificial liver devices. Hepatology 34 (2001) 447-455
6. Baccarani U., Donini A., Sanna A., Risaliti A., Cariani A., Nardo B., et al. First report of cryopreserved human hepatocytes based bioartificial liver successfully used as a bridge to liver transplantation. Am J Transplant 4 (2003) 286-289
7. Donato M.T., Castell J.V., and Gómez-Lechón M.J. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J Hepatol 31 (1999) 542-549
8. Harimoto N., Taketomi A., Kitagawa D., Kuroda Y., Itoh S., Gion T., et al. The newly established human hepatocyte cell line: application for the bioartificial liver. J Hepatol 42 (2005) 557-564
9. David B., Dufresne M., Nagel M.D., and Legallais C. In vitro assessment of encapsulated C3A hepatocyte functions in a fluidized bed bioreactor. Biotechnol Prog 20 (2004) 1204-1212
10. Suzuki A., Nakauchi H., and Taniguchu H. In vitro production of functionally mature hepatocytes from prospectively isolated hepatic stem cells. Cell Transplant 12 (2003) 469-473
11. Baccarani U., Sanna A., Cariani A., Sainz M., Adani G.L., Lorenzin D., et al. Cryopreserved human hepatocytes from cell bank: in vitro function and clinical application. Transplant Proc 37 (2005) 256-259
12. Alonso A., Fernandez-Rivera C., Villaverde P., Oliver J., Cillero S., Lorenzo D., et al. Transplantation from non-heart-beating donors: a single-center 10-year experience. Transplant Proc 37 (2005) 3658-3660
13. Nunez J.R., Del Rio F., Lopez E., Moreno M.A., Soria A., and Parra D. Non-heart-beating donors: an excellent choice to increase the donor pool. Transplant Proc 37 (2005) 3651-3654
14. Terry C., Mitry R.R., Lehec S.C., Muiesan P., Rela M., Heaton N.D., et al. The effects of cryopreservation on human hepatocytes obtained from different sources of liver tissue. Cell Transplant 14 (2005) 585-594
15. Gatti S, Gramignoli R, Ambrosone A, Colombo F, Fassati LR, Porretti L, et al. Uso di epatociti vitali prelevati dopo ischemia calda. Italian Patent N. MI2005A000597 (8/4/2005).
16. Lilja H., Arkadopoulos N., Blanc P., Educhi S., Middleton Y., Meurling S., et al. Fetal rat hepatocytes: isolation, characterization and transplantation in the Nagase analbuminemic rats. Transplantation 64 (1997) 1240-1248
17. Kunieda T., Maruyama M., Okitsu T., Shibata N., Takesue M., Totsugawa T., et al. Cryopreservation of primarily isolated porcine hepatocytes with UW solution. Cell Transplant 12 (2003) 607-616
18. Sugimachi K., Sosef M.N., Baust J.M., Fowler A., Tompkins R.G., and Toner M. Long-term function of cryopreserved rat hepatocytes in a coculture system. Cell Transplant 13 (2004) 187-195
19. Sokal E.M., Smets F., Bourgois A., Van Maldergem L., Buts J.P., Reding R., et al. Hepatocyte transplantation in 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76 (2003) 735-738
20. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338 (1998) 1422-1426
21. He X.S., Ma Y., Wu L.W., Ju W.Q., Wu J.L., Hu R.D., et al. Safe time to warm ischemia and post-transplant survival of liver graft from non-heart-beating donors. World J Gastroenterol 10 (2004) 3157-3160
22. de la Iglesia N., Mukhtar M., Seoane J., Guinovart J.J., and Agius L. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte. J Biol Chem 275 (2000) 10597-10603
23. Mitry R.R., Hughes R.D., and Dhawan A. Progress in human hepatocytes: isolation, culture and cryopreservation. Cell Dev Biol 13 (2002) 463-467
24. Cho J.J., Joseph B., Sappal B.S., Giri R.K., Wang R., Ludlow J.W., et al. Analysis of the functional integrity of cryopreserved human liver cells including xenografting in immunodeficient mice to address suitability for clinical applications. Liver Int 24 (2004) 361-370
25. Sosef M.N., Baust J., Sugimachi K., Fowler A., Tompkins R., and Toner M. Cryopreservation of isolated primary rat hepatocytes: enhanced survival and long-term hepatospecific function. Ann Surg 241 (2005) 125-133
26. Hengstler J.G., Utesch D., Steinberg P., Platt K., Diener B., Ringel M., et al. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32 (2000) 81-118
27. Terry C., Dhawan A., Mitry R.R., Lehec S.C., and Hughes R.D. Preincubation of rat and human hepatocytes with cytoprotectants prior to cryopreservation can improve viability and function upon thawing. Liver Transpl 11 (2005) 1533-1540